This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent. Top assignee: Inscripta, Inc.. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2023
Title: Nandini Krishnamurthy: Innovator in Lysine Production
Introduction
Nandini Krishnamurthy is a prominent inventor based in Boulder, CO. She has made significant contributions to the field of biotechnology, particularly in enhancing lysine production through innovative genetic mutations. With a total of three patents to her name, Nandini is recognized for her groundbreaking work in this area.
Latest Patents
Nandini's latest patents include "Rationally-designed mutations to the thrA gene for enhanced lysine production." This patent focuses on various mutations in the thrA gene that lead to improved lysine production, which can be utilized in supplements and nutraceuticals. Another notable patent is "Genome-wide rationally-designed mutations leading to enhanced lysine production," which discusses different variants in both coding and noncoding regions that contribute to increased lysine production for similar applications.
Career Highlights
Nandini currently works at Inscripta, Inc., a company known for its innovative approaches in genetic engineering. Her work has positioned her as a leader in the field, and her patents reflect her commitment to advancing biotechnological solutions.
Collaborations
Throughout her career, Nandini has collaborated with esteemed colleagues such as Richard Fox and Daniel Held. These partnerships have allowed her to expand her research and contribute to significant advancements in lysine production.
Conclusion
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile